La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Shanghai MicroPort Endovascular MedTech Résultats passés
Passé contrôle des critères 5/6
Shanghai MicroPort Endovascular MedTech has been growing earnings at an average annual rate of 28.4%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 30.1% per year. Shanghai MicroPort Endovascular MedTech's return on equity is 13.4%, and it has net margins of 43.8%.
Informations clés
28.4%
Taux de croissance des bénéfices
25.3%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | 16.0% |
Taux de croissance des recettes | 30.1% |
Rendement des fonds propres | 13.4% |
Marge nette | 43.8% |
Prochaine mise à jour des résultats | 27 Aug 2024 |
Mises à jour récentes des performances passées
Recent updates
Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends
Aug 15Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel
Jun 29These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely
Apr 29Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem
Apr 09Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't
Mar 25Ventilation des recettes et des dépenses
Comment Shanghai MicroPort Endovascular MedTech gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
31 Mar 24 | 1,260 | 552 | 190 | 160 |
31 Dec 23 | 1,187 | 492 | 187 | 173 |
30 Sep 23 | 1,121 | 444 | 193 | 167 |
30 Jun 23 | 1,059 | 421 | 191 | 161 |
31 Mar 23 | 924 | 358 | 160 | 139 |
31 Dec 22 | 897 | 357 | 153 | 138 |
30 Sep 22 | 839 | 367 | 125 | 123 |
30 Jun 22 | 781 | 346 | 117 | 114 |
31 Mar 22 | 745 | 338 | 113 | 115 |
31 Dec 21 | 685 | 316 | 105 | 102 |
30 Sep 21 | 652 | 302 | 97 | 99 |
30 Jun 21 | 618 | 279 | 92 | 91 |
31 Mar 21 | 569 | 257 | 90 | 85 |
31 Dec 20 | 470 | 215 | 79 | 73 |
30 Sep 20 | 414 | 192 | 76 | 61 |
30 Jun 20 | 377 | 177 | 72 | 53 |
31 Mar 20 | 341 | 156 | 71 | 51 |
31 Dec 19 | 334 | 142 | 71 | 50 |
30 Sep 19 | 306 | 127 | 65 | 42 |
30 Jun 19 | 282 | 115 | 60 | 37 |
31 Mar 19 | 257 | 103 | 66 | 37 |
31 Dec 18 | 231 | 91 | 53 | 30 |
31 Dec 17 | 165 | 63 | 32 | 20 |
31 Dec 16 | 125 | 41 | 28 | 20 |
Des revenus de qualité: 688016 has high quality earnings.
Augmentation de la marge bénéficiaire: 688016's current net profit margins (43.8%) are higher than last year (38.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 688016's earnings have grown significantly by 28.4% per year over the past 5 years.
Accélération de la croissance: 688016's earnings growth over the past year (54.1%) exceeds its 5-year average (28.4% per year).
Bénéfices par rapport au secteur d'activité: 688016 earnings growth over the past year (54.1%) exceeded the Medical Equipment industry 1.7%.
Rendement des fonds propres
ROE élevé: 688016's Return on Equity (13.4%) is considered low.